{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:07:28Z","timestamp":1789391248695,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"crossref","award":["2461"],"award-info":[{"award-number":["2461"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jad-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jad.2014.05.015","type":"journal-article","created":{"date-parts":[[2014,5,24]],"date-time":"2014-05-24T03:47:04Z","timestamp":1400903224000},"page":"201-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: A randomized double blind placebo controlled clinical trial"],"prefix":"10.1016","volume":"166","author":[{"given":"Ali","family":"Sahraian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Bigdeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Ghanizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Akhondzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jad.2014.05.015_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1503\/jpn.110109","article-title":"Association between the NMDA glutamate receptor GRIN2B gene and obsessive\u2013compulsive disorder","volume":"37","author":"Alonso","year":"2012","journal-title":"J. Psychiatry Neurosci."},{"issue":"5","key":"10.1016\/j.jad.2014.05.015_bib2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.4088\/JCP.09m05266gre","article-title":"Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive\u2013compulsive disorder","volume":"72","author":"Berlin","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.05.015_bib3","doi-asserted-by":"crossref","first-page":"7288","DOI":"10.4076\/1757-1626-2-7288","article-title":"Treatment with aripiprazole and topiramate in an obese subject with borderline personality disorder, obsessive\u2013compulsive symptoms and bulimia nervosa: a case report","volume":"2","author":"Bruno","year":"2009","journal-title":"Cases J."},{"issue":"Suppl. 1","key":"10.1016\/j.jad.2014.05.015_bib4","first-page":"S130","article-title":"Co-morbidity of bipolar affective disorder and obsessive compulsive disorder in a Bedford community psychiatry team","volume":"23","author":"Darby","year":"2011","journal-title":"Psychiatr Danubina"},{"issue":"4","key":"10.1016\/j.jad.2014.05.015_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00002826-200307000-00010","article-title":"Adjuvant topiramate administration: a pharmacologic strategy for addressing NMDA receptor hypofunction in schizophrenia","volume":"26","author":"Deutsch","year":"2003","journal-title":"Clin. Neuropharmacol."},{"issue":"8","key":"10.1016\/j.jad.2014.05.015_bib6","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1399-5618.2008.00637.x","article-title":"Treatment-emergent mania\/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder","volume":"10","author":"Gao","year":"2008","journal-title":"Bipolar Disord."},{"issue":"7","key":"10.1016\/j.jad.2014.05.015_bib7","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1017\/S0033291711002637","article-title":"Co-morbid anxiety disorders in bipolar disorder and major depression: familial aggregation and clinical characteristics of co-morbid panic disorder, social phobia, specific phobia and obsessive\u2013compulsive disorder","volume":"42","author":"Goes","year":"2012","journal-title":"Psychol. Med."},{"issue":"11","key":"10.1016\/j.jad.2014.05.015_bib8","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2014.05.015_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/01.yic.0000199453.54799.cc","article-title":"Topiramate plus paroxetine in treatment-resistant obsessive\u2013compulsive disorder","volume":"21","author":"Hollander","year":"2006","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.jad.2014.05.015_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1399-5618.2010.00789.x","article-title":"Impact of obsessive\u2013compulsive disorder on the antimanic response to olanzapine therapy in youth with bipolar disorder","volume":"12","author":"Joshi","year":"2010","journal-title":"Bipolar Disord."},{"issue":"3","key":"10.1016\/j.jad.2014.05.015_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.comppsych.2009.07.006","article-title":"Impact of obsessive\u2013compulsive disorder comorbidity on the sociodemographic and clinical features of patients with bipolar disorder","volume":"51","author":"Koyuncu","year":"2010","journal-title":"Compr. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2014.05.015_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1034\/j.1399-5618.2000.020111.x","article-title":"Comorbidity of obsessive\u2013compulsive disorder in recovered inpatients with bipolar disorder","volume":"2","author":"Kruger","year":"2000","journal-title":"Bipolar Disord."},{"issue":"1","key":"10.1016\/j.jad.2014.05.015_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1399-5618.2006.00276.x","article-title":"Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials","volume":"8","author":"Kushner","year":"2006","journal-title":"Bipolar Disord."},{"issue":"8","key":"10.1016\/j.jad.2014.05.015_bib14","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1176\/appi.ajp.2013.13010144","article-title":"Clozapine-induced obsessive\u2013compulsive symptoms in bipolar disorder","volume":"170","author":"Lemke","year":"2013","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2014.05.015_bib15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1176\/appi.ajp.163.2.232","article-title":"Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers","volume":"163","author":"Leverich","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2014.05.015_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.comppsych.2009.11.001","article-title":"Correlates and impact of obsessive\u2013compulsive comorbidity in bipolar disorder","volume":"51","author":"Magalhaes","year":"2010","journal-title":"Compr. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2014.05.015_bib17","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/da.20259","article-title":"Lifetime comorbidity of obsessive\u2013compulsive disorder with psychiatric disorders in a community sample","volume":"24","author":"Mohammadi","year":"2007","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2014.05.015_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-244X-4-2","article-title":"Prevalence of obsessive\u2013compulsive disorder in Iran","volume":"4","author":"Mohammadi","year":"2004","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2014.05.015_bib19","doi-asserted-by":"crossref","DOI":"10.1017\/S1092852912000065","article-title":"Topiramate augmentation in resistant OCD: a double-blind placebo-controlled clinical trial","author":"Mowla","year":"2010","journal-title":"CNS Spectr"},{"issue":"1","key":"10.1016\/j.jad.2014.05.015_bib20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eurpsy.2004.09.015","article-title":"Topiramate related obsessive\u2013compulsive disorder","volume":"20","author":"Ozkara","year":"2005","journal-title":"Eur. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2014.05.015_bib21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.pharmthera.2011.09.006","article-title":"Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment","volume":"132","author":"Pittenger","year":"2011","journal-title":"Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.jad.2014.05.015_bib22","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.4088\/JCP.v67n1105","article-title":"Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial","volume":"67","author":"Roy Chengappa","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2014.05.015_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/01.jcp.0000220524.44905.9f","article-title":"The effects of topiramate adjunctive treatment added to antidepressants in patients with resistant obsessive\u2013compulsive disorder","volume":"26","author":"Rubio","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.jad.2014.05.015_bib24","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/da.21932","article-title":"Clinical features of bipolar disorder comorbid with anxiety disorders differ between men and women","volume":"29","author":"Saunders","year":"2012","journal-title":"Depress. Anxiety"},{"issue":"12","key":"10.1016\/j.jad.2014.05.015_bib25","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1176\/appi.ajp.161.12.2222","article-title":"Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"161","author":"Simon","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"3\u20134","key":"10.1016\/j.jad.2014.05.015_bib26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jpsychires.2006.08.004","article-title":"The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder","volume":"41","author":"Simon","year":"2007","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.jad.2014.05.015_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0165-0327(99)00021-X","article-title":"Is episodic obsessive compulsive disorder bipolar? A report of four cases.","volume":"56","author":"Swartz","year":"1999","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.jad.2014.05.015_bib28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1440-1819.2006.01520.x","article-title":"Topiramate may induce obsessive\u2013compulsive disorder","volume":"60","author":"Thuile","year":"2006","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.jad.2014.05.015_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/da.20118","article-title":"Topiramate augmentation in treatment-resistant obsessive\u2013compulsive disorder: a retrospective, open-label case series","volume":"23","author":"Van Ameringen","year":"2006","journal-title":"Depress. Anxiety"},{"issue":"1","key":"10.1016\/j.jad.2014.05.015_bib30","article-title":"Topiramate for acute affective episodes in bipolar disorder","author":"Vasudev","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"issue":"11","key":"10.1016\/j.jad.2014.05.015_bib31","first-page":"747","article-title":"Topiramate augmentation in treatment-resistant obsessive\u2013compulsive disorder","volume":"50","author":"Vinkers","year":"2008","journal-title":"Tijdschr Psychiatr"},{"issue":"4","key":"10.1016\/j.jad.2014.05.015_bib32","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.pbb.2011.10.007","article-title":"The role of glutamate signaling in the pathogenesis and treatment of obsessive\u2013compulsive disorder","volume":"100","author":"Wu","year":"2012","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032714003036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032714003036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T19:22:30Z","timestamp":1538594550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032714003036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":32,"alternative-id":["S0165032714003036"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2014.05.015","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: A randomized double blind placebo controlled clinical trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2014.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}